Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · IEX Real-Time Price · USD
10.82
-0.10 (-0.92%)
Jul 17, 2024, 10:05 AM EDT - Market closed

Company Description

Bellevue Life Sciences Acquisition Corp. does not have significant operations.

It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry.

The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition logo
Country United States
Founded 2020
IPO Date Feb 10, 2023
Industry Shell Companies
Sector Financials
CEO Kuk Hyoun Hwang

Contact Details

Address:
10900 Ne 4th Street, Suite 2300
Bellevue, Washington 98004
United States
Phone 425-635-7700

Stock Details

Ticker Symbol BLAC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $10.00
CIK Code 0001840425
CUSIP Number 079174108
ISIN Number US0791741087
Employer ID 84-5052822
SIC Code 3841

Key Executives

Name Position
Kuk Hyoun Hwang Chief Executive Officer and Director
David Jin Yoo Chief Financial Officer

Latest SEC Filings

Date Type Title
Jul 16, 2024 8-K Current Report
Jun 28, 2024 S-4 Filing
Jun 27, 2024 8-K Current Report
Jun 13, 2024 8-K Current Report
May 30, 2024 425 Filing
May 30, 2024 8-K Current Report
May 15, 2024 10-Q Quarterly Report
May 14, 2024 8-K Current Report
May 13, 2024 425 Filing
May 13, 2024 8-K Current Report